हमारा समूह 1000 से अधिक वैज्ञानिक सोसायटी के सहयोग से हर साल संयुक्त राज्य अमेरिका, यूरोप और एशिया में 3000+ वैश्विक सम्मेलन श्रृंखला कार्यक्रम आयोजित करता है और 700+ ओपन एक्सेस जर्नल प्रकाशित करता है जिसमें 50000 से अधिक प्रतिष्ठित व्यक्तित्व, प्रतिष्ठित वैज्ञानिक संपादकीय बोर्ड के सदस्यों के रूप में शामिल होते हैं।
ओपन एक्सेस जर्नल्स को अधिक पाठक और उद्धरण मिल रहे हैं
700 जर्नल और 15,000,000 पाठक प्रत्येक जर्नल को 25,000+ पाठक मिल रहे हैं
Ramcharan Naidu
Drug metabolism and pharmacokinetics play pivotal roles in determining the efficacy and safety of pharmaceutical compounds. This study delves into the intricate interplay between drug metabolism processes and their impact on pharmacokinetic profiles to optimize therapeutic outcomes. Through comprehensive in vitro and in vivo investigations, a comprehensive understanding of the enzymatic pathways, including cytochrome P450 enzymes and phase II conjugation reactions, is established. The investigation extends to elucidating the factors influencing drug absorption, distribution, metabolism, and excretion (ADME). Quantitative analysis of drug bioavailability, clearance, and half-life is conducted using sophisticated mathematical models, shedding light on the complex kinetics of drug interactions within the body. Furthermore, the influence of genetic polymorphisms on drug metabolism pathways is explored, emphasizing the need for personalized medicine approaches. In the pursuit of enhancing drug development strategies, the role of transporter proteins and their involvement in drug distribution across various physiological barriers is examined. The study also assesses the potential for drug-drug interactions arising from overlapping metabolic pathways or competitive inhibition of transporters, thus underlining the significance of assessing polypharmacy scenarios. Through integration of experimental data and computational simulations, this research offers insights into optimizing dosing regimens and minimizing adverse effects. The findings underscore the importance of bridging the gap between preclinical experiments and clinical trials, facilitating a smoother transition from bench to bedside. Ultimately, a comprehensive comprehension of drug metabolism and pharmacokinetics empowers clinicians and researchers alike to make informed decisions for the advancement of therapeutic interventions.